中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

外科经导管二尖瓣修复的研究进展

查看全文

二尖瓣返流是心脏外科中常见的疾病,病因较多,可大致分为原发性二尖瓣返流和继发性二尖瓣返流两类。随着近年来心脏导管技术的发展,更多的高风险二尖瓣返流患者因不能耐受开胸手术而接受了导管介入治疗,并取得了令人满意的效果。目前针对二尖瓣返流的导管技术包括瓣叶修复、瓣环环缩以及人工腱索植入。相较于原发性二尖瓣返流,继发性二尖瓣返流病理生理机制复杂,手术效果通常不理想,因此本文将以外科经导管介入二尖瓣成形术为中心,以治疗原发性二尖瓣返流为重点,以外科的角度从手术风险、手术种类、展望三个方面对经导管二尖瓣修复的研究进展综述。

Mitral regurgitation (MR) with multi-pathogenesis is a common disease in cardiac surgery department. MR can be classified into two categories-primary mitral regurgitation and secondary mitral regurgitation. With the development of cardiac intervention, numerous patients who cannot tolerate open heart surgery for the reason of high risk of surgery receive the treatment of intervention and achieve the favorable endpoint. The technique of transcatheter therapy which could be used to treat MR is comprised of leaflet repair, annuloplasty and implantation of artificial chordae. Comparing to primary mitral regurgitation, surgical effect of secondary mitral regurgitation is not desirable for the reasons of complex pathophysiologic mechanism. Hence, based on the perspective of surgeon, we will introduce the research progress of transcatheter interventional mitral valve repair which is focused on the treatment of primary mitral valve regurgitation and reviewed from three aspects of surgical risks, surgical types and outlook.

关键词: 外科; 经导管; 二尖瓣返流; 瓣叶修复

Key words: Surgery; Transcatheter; Mitral regurgitation; Valve leaflet repair

1. Ibánez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Española de Cardiología (English Edition), 2017, 70(12): 1082.
2. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes. Journal of Nuclear Cardiology, 2017, 24(2): 439-463.
3. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). European Journal of Cardio-Thoracic Surgery, 2012, 42(4): S1-S44.
4. Lim DS, Reynolds MR, Feldman T, et al. Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients With Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair. J Am Coll Cardio, 2014, 64(2): 182-192.
5. Lapar DJ, Isbell JM, Crosby IK, et al. Multicenter evaluation of high-risk mitral valve operations: implications for novel transcatheter valve therapies. Ann Thorac Surg, 2014, 98(6): 2032-2038.
6. Paranskaya L, D Ancona G, Bozdag-Turan I, et al. Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata. EuroIntervention, 2012, 8(5): 571-578.
7. Puls M, Tichelbäcker T, Bleckmann A, et al. Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip. EuroIntervention, 2014, 9(12): 1407-1417.
8. Velu JF, Kortlandt FA, Hendriks T, et al. Percutaneous Mitral Valve Repair. J Am Coll Cardiol, 2017, 69(23): 2875-2876.
9. Velu JF, Kortlandt FA, Hendriks T, et al. Comparison of outcome after percutaneous mitral valve repair with the mitraclip in patients with versus without atrial fibrillation. The American Journal of Cardiology, 2017, 120(11): 2035-2040.
10. Jabs A, von Bardeleben R, Boekstegers P, et al. Effects of atrial fibrillation and heart rate on percutaneous mitral valve repair with MitraClip: results from the TRAnscatheter Mitral valve Interventions (TRAMI) registry. EuroIntervention, 2017, 12(14): 1697-1705.
11. Saji M, Katz MR, Ailawadi G, et al. Predictive value of age-adjusted charlson co-morbidity index for 1-, 3-, and 5-year mortality in patients requiring transcatheter mitral valve repair. The American Journal of Cardiology, 2017, 120(2): 309-314.
12. Ledwoch J, Franke J, Lubos E, et al. Prognostic value of preprocedural 6-min walk test in patients undergoing transcatheter mitral valve repair—insights from the German transcatheter mitral valve interventions registry. Clinical Research in Cardiology, 2018, 107(3): 241-248.
13. Itabashi Y, Utsunomiya H, Kubo S, et al. Different indicators for postprocedural mitral stenosis caused by single- or multiple-clip implantation after percutaneous mitral valve repair. Journal of Cardiology, 2018, 71(4): 336-345.
14. Sorini Dini C, Landi D, Meucci F, et al. Unexpected delayed complete atrioventricular block after Cardioband implantation. Catheterization and Cardiovascular Interventions, 2018.
15. Toyama K, Rader F, Kar S, et al. Iatrogenic Atrial Septal Defect After Percutaneous Mitral Valve Repair With the MitraClip System. American J Cardio, 2018, 121(4): 475-479.
16. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease. Revista Española de Cardiología (English Edition), 2018, 71(2): 110.
17. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
18. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary. Circulation, 2014, 129(23): 2440.
19. St. Goar FG, Fann JI, Komtebedde J, et al Endovascular Edge-to-Edge Mitral Valve Repair. Circulation, 2003, 108(16): 1990-1993.
20. Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients. J Am Coll Cardio, 2014, 64(2): 172-181.
21. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip Therapy in Europe. J Am Coll Cardio, 2013, 62(12): 1052-1061.
22. Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair. J Am Coll Cardio, 2012, 59(2): 130-139.
23. Scandura S, Capranzano P, Caggegi A, et al. Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry. International Journal of Cardiology, 2016, 224: 440-446.
24. Swaans MJ, Bakker ALM, Alipour A, et al. Survival of Transcatheter Mitral Valve Repair Compared With Surgical and Conservative Treatment in High-Surgical-Risk Patients. JACC: Cardiovascular Interventions, 2014, 7(8): 875-881.
25. Doshi R, Shlofmitz E, Shah J, et al. Comparison of transcatheter mitral valve repair versus surgical mitral valve repair in patients with advanced kidney disease (from the national inpatient sample). The American Journal of Cardiology, 2018, 121(6): 762-767.
26. Feldman T, Kar S, Elmariah S, et al. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation. J Am Coll Cardio, 2015, 66(25): 2844-2854.
27. Kortlandt F, Velu J, Schurer R, et al. Survival After MitraClip treatment compared to surgical and conservative treatment for high-surgical-risk patients with mitral regurgitation. Circulation: Cardiovascular Interventions, 2018, 11(6): e5985.
28. Kar S, Feldman T, Qasim A, et al. Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients. Heart, 2018: 2017-312605.
29. Takagi H, Ando T, Umemoto T. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. International Journal of Cardiology, 2017, 228: 289-294.
30. Kaneko H, Neuss M, Weissenborn J, et al. Impact of residual mitral regurgitation after MitraClip implantation. International Journal of Cardiology, 2017, 227: 813-819.
31. Rihal CS, Sorajja P, Booker JD, et al. Principles of Percutaneous Paravalvular Leak Closure. JACC: Cardiovascular Interventions, 2012, 5(2): 121-130.
32. Taramasso M, Zuber M, Gruner C, et al. First-in-man report of residual " intra-clip” regurgitation between two MitraClips treated by AMPLATZER Vascular Plug II. EuroIntervention, 2016, 11(13): 1537-1540.
33. Kubo S, Cox JM, Mizutani Y, et al. Transcatheter procedure for residual mitral regurgitation after mitraclip implantation using amplatzer duct occluder II. JACC: Cardiovascular Interventions, 2016, 9(12): 1280-1288.
34. Liu X, Shi J, Feng X, et al. Short-term and 1-year outcomes after MitraClip therapy in functional versus degenerative mitral regurgitation patients: a systematic review and meta-analysis. Journal of Thoracic Disease, 2018, 10(7): 4156-4168.
35. Giannini C, D'Ascenzo F, Fiorelli F, et al. A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients. ESC Heart Failure, 2018.
36. De Rosa Roberta, Silverio Angelo, Baldi Cesare, et al. Transcatheter Repair of Functional Mitral Regurgitation in Heart Failure Patients ― A Meta-Analysis of 23 Studies on MitraClip Implantation ―. Circulation Journal, 2018, 82(11): 2800-2810.
37. Baldino G, Persi F, Mortola P, et al. An Alternative Technique to Achieve Haemostasis During PEVAR Using Perclose ProGlide. EJVES Short Reports, 2018, 41: 8-9.
38. Mack MJ, Abraham WT, Lindenfeld J, et al. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. American Heart Journal, 2018, 205: 1-11.
39. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. New England Journal of Medicine, 2018.
40. Mcmurray JJV, Packer M, Desai AS, et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. New England Journal of Medicine, 2014, 371(11): 993-1004.
41. Grasso C, Popolo RA. The PASCAL transcatheter mitral valve repair system for the treatment of mitral regurgitation: another piece to the puzzle of edge-to-edge technique. J Thorac Dis, 2017, 9(12): 4856-4859.
42. Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet, 2017, 390(10096): 773-780.
43. Wang S, Meng X, Luo Z, et al. Transapical Beating-Heart Mitral Valve Repair Using a Novel Artificial Chordae Implantation System. The Annals of thoracic surgery, 2018, 106(5): e265-e267.
44. Tiroch K, Brinkmann H, Koudonas D, et al. "First-in-man" MitraClip via pulmonary vein access through a right mini-thoracotomy in a patient with agenesis of the inferior vena cava. EuroIntervention, 2015, 10(11): 1204-1207.
45. Frerker C, Meincke F, Seibert H, et al. MitraClip® via direct right atrial access in case of a missing inferior vena cava. EuroIntervention, 2013, 9(5): 643-647.
46. Okada A, Kanzaki H, Amaki M, et al. Successful Treatment of Mitral Regurgitation after Transapical Transcatheter Aortic Valve Implantation by Percutaneous Edge-to-edge Mitral Valve Repair (MitraClip®) -The First Combination Therapy Performed in Japan-. Internal Medicine, 2018, 57(8): 1105-1109.
47. Nickenig G, Hammerstingl C. The Mitralign transcatheter direct mitral valve annuloplasty system. EuroIntervention, 2015, 14(W): W62-W63.
48. Nickenig G, Hammerstingl C, Schueler R, et al. Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation. JACC: Cardiovascular Interventions, 2016, 9(19): 2039-2047.
49. Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. European Heart Journal, 2016, 37(10): 817-825.
50. Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. European Heart Journal, 2018.
51. von Bardeleben RS, Colli A, Schulz E, et al. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fusion imaging. European Heart Journal, 2018, 39(15): 1314-1315.
52. Latib A, Ancona MB, Ferri L, et al. Percutaneous Direct Annuloplasty With Cardioband to Treat Recurrent Mitral Regurgitation After MitraClip Implantation. JACC: Cardiovascular Interventions, 2016, 9(18): e191-e192.
53. Stephan Von Bardeleben R, Tamm A, Emrich T, et al. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband. European Heart Journal, 2017, 38(9): 690.
54. Kwon MH, Lee LS, Cevasco M, et al. Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation. J Thorac Cardiovasc Surg, 2013, 146(3): 616-622.
55. Shapira Y. The Cardioband annuloplasty system: is it ready for prime time? Eur Heart J, 2018.
56. Colli A, Zucchetta F, Torregrossa G, et al. Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg, 2015, 4(3): 295-297.
57. Rucinskas K, Janusauskas V, Zakarkaite D, et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: Early results of a single-center experience. The Journal of Thoracic and Cardiovascular Surgery, 2014, 147(1): 95-99.
58. Colli A, Manzan E, Zucchetta F, et al. Transapical off-pump mitral valve repair with Neochord implantation: Early clinical results. International Journal of Cardiology, 2016, 204: 23-28.
59. Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation†. European Journal of Cardio-Thoracic Surgery, 2018, 54(3): 460-466.
60. Colli A, Besola L, Montagner M, et al. Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation. International Journal of Cardiology, 2018, 257: 235-237.
61. Colli A, Besola L, Bizzotto E, et al. Edge-to-edge mitral valve repair with transapical neochord implantation. The Journal of Thoracic and Cardiovascular Surgery, 2018, 156(1): 144-148.
62. Tang GHL, Szeto WY. Transapical simultaneous edge-to-edge neochord repair: A new way to manage bileaflet prolapse? The Journal of Thoracic and Cardiovascular Surgery, 2018, 156(1): 149-150.
63. Gammie JS, Wilson P, Bartus K, et al. Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device. Circulation, 2016, 134(3): 189-197.
64. Gammie JS, Bartus K, Gackowski A, et al. Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device. J Am Coll Cardio, 2018, 71(1): 25-36.
65. Pedersen WR, Block P, Leon M, et al. iCoapsys mitral valve repair system: Percutaneous implantation in an animal model. Catheterization and Cardiovascular Interventions, 2008, 72(1): 125-131.